Arthritis and CV disease
This article was originally published in The Tan Sheet
Executive Summary
Rheumatoid arthritis patients are at greater risk for cardiovascular disease, according to a study published in Arthritis Research & Therapy June 29. C-reactive protein is an example of the type of inflammatory mechanisms elevated in RA, Kenneth Warrington, MD, Mayo Clinic, et al., state. The retrospective case control study evaluated 203 patients with coronary artery disease 75 of whom also had rheumatoid arthritis. A coronary angiography was performed for evaluation of CAD within the first 12 months of the disease. The authors found "a trend for increased CV death in patients with RA," while the overall rate of non-fatal CV events was similar for both groups...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.